GENOVESE, GIOVANNI
 Distribuzione geografica
Continente #
EU - Europa 5.627
NA - Nord America 5.569
AS - Asia 5.083
SA - Sud America 792
AF - Africa 144
OC - Oceania 73
Continente sconosciuto - Info sul continente non disponibili 9
Totale 17.297
Nazione #
US - Stati Uniti d'America 5.276
CN - Cina 1.560
IT - Italia 1.315
SG - Singapore 1.274
GB - Regno Unito 1.101
BR - Brasile 566
DE - Germania 501
ES - Italia 413
HK - Hong Kong 388
SE - Svezia 358
IN - India 350
RU - Federazione Russa 331
TR - Turchia 331
FR - Francia 328
JP - Giappone 328
IE - Irlanda 194
CA - Canada 183
ID - Indonesia 174
NL - Olanda 164
VN - Vietnam 162
DK - Danimarca 159
FI - Finlandia 143
KR - Corea 111
BE - Belgio 101
CH - Svizzera 100
AR - Argentina 72
AT - Austria 66
MX - Messico 66
PL - Polonia 66
AU - Australia 60
CO - Colombia 57
TW - Taiwan 53
TH - Thailandia 51
GR - Grecia 47
IR - Iran 45
PT - Portogallo 45
PH - Filippine 44
RO - Romania 39
CL - Cile 38
UA - Ucraina 37
SA - Arabia Saudita 32
CI - Costa d'Avorio 31
BD - Bangladesh 24
EG - Egitto 24
HU - Ungheria 22
ZA - Sudafrica 22
IL - Israele 21
MY - Malesia 18
AE - Emirati Arabi Uniti 17
CZ - Repubblica Ceca 17
EC - Ecuador 17
IQ - Iraq 17
SK - Slovacchia (Repubblica Slovacca) 16
MA - Marocco 14
UZ - Uzbekistan 13
PK - Pakistan 12
CR - Costa Rica 11
KE - Kenya 11
NZ - Nuova Zelanda 11
PE - Perù 11
SI - Slovenia 11
VE - Venezuela 11
HR - Croazia 10
TN - Tunisia 10
DZ - Algeria 9
GD - Grenada 8
LB - Libano 8
GE - Georgia 7
LT - Lituania 7
NO - Norvegia 7
PY - Paraguay 7
BH - Bahrain 6
UY - Uruguay 6
AP - ???statistics.table.value.countryCode.AP??? 5
BG - Bulgaria 5
BO - Bolivia 5
JO - Giordania 5
RS - Serbia 5
SC - Seychelles 5
AZ - Azerbaigian 4
BY - Bielorussia 4
MD - Moldavia 4
MO - Macao, regione amministrativa speciale della Cina 4
NG - Nigeria 4
NP - Nepal 4
PA - Panama 4
SV - El Salvador 4
DO - Repubblica Dominicana 3
EU - Europa 3
ME - Montenegro 3
OM - Oman 3
PS - Palestinian Territory 3
AL - Albania 2
AM - Armenia 2
CU - Cuba 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
KG - Kirghizistan 2
Totale 17.258
Città #
Singapore 683
Southend 667
Ashburn 537
Milan 428
Chandler 370
Fairfield 293
Hong Kong 287
Beijing 231
Dallas 202
Ann Arbor 196
Dublin 183
Princeton 165
Wilmington 162
Houston 145
Redwood City 142
Tokyo 139
Seattle 135
Council Bluffs 134
Madrid 131
Santa Clara 128
Los Angeles 124
New York 124
Woodbridge 123
Jakarta 121
Frankfurt am Main 116
Helsinki 112
Istanbul 110
Guangzhou 95
Cambridge 94
São Paulo 86
Bengaluru 80
London 77
Hefei 72
Buffalo 71
Shanghai 71
Des Moines 67
Central 66
Nanjing 66
San Jose 66
Barcelona 64
Brussels 60
Dearborn 55
Hangzhou 55
Ankara 54
Rome 54
Paris 53
Moscow 48
Rio de Janeiro 43
Dong Ket 42
Mumbai 42
Amsterdam 41
Hamburg 41
Munich 41
Zurich 41
Berlin 39
Jinan 38
Seoul 38
Taipei 38
Toronto 38
Atlanta 37
Chicago 37
Vienna 36
San Diego 34
Florence 33
Montreal 33
Cangzhou 32
Tianjin 32
Valencia 32
Abidjan 31
Duncan 31
Boardman 30
Ho Chi Minh City 30
Phoenix 30
Chennai 29
Changsha 28
Brooklyn 27
Buenos Aires 26
Medellín 26
San Francisco 26
Chengdu 25
Izmir 25
Nuremberg 25
Ottawa 25
Shenyang 25
Athens 23
Campinas 23
Columbus 23
Warsaw 23
New Delhi 22
Trieste 22
Central District 21
Düsseldorf 21
Hanoi 21
Jeddah 21
Manchester 21
Perugia 21
Bologna 20
Stockholm 20
Turin 20
Copenhagen 18
Totale 9.109
Nome #
Evidence for a “window of opportunity” in hidradenitis suppurativa treated with adalimumab: a retrospective, real‐life multicenter cohort study 2.694
Predictors of response to omalizumab and relapse in chronic spontaneous urticaria: a study of 470 patients 974
Photobiomodulation as potential novel third line tool for non-invasive treatment of Hidradenitis Suppurativa 641
Lymphocytic variant of hypereosinophilic syndrome presenting with polymorphic cutaneous manifestations and nonspecific histopathological findings 470
Efficacy of a detergent combined with a moisturiser for the treatment of pruritus associated with xerosis in an elderly population affected by Kaposi's sarcoma 389
Clinical and immunopathological features of idiopathic cutaneous IgM/IgG vasculitis versus idiopathic skin-limited IgA vasculitis 370
Late-onset post-mammoplasty pyoderma gangrenosum treated with tobacco-pouch suture combined with oral corticosteroids 320
How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group 314
Phthiriasis of the eyelashes 261
Refractory disseminated superficial actinic porokeratosis effectively treated with cholesterol/lovastatin cream: a case report 238
Clinical Response and Quality of Life in Patients with Severe Atopic Dermatitis Treated with Dupilumab : A Single-Center Real-Life Experience 229
Hidradenitis suppurativa: the "bright side" of autoinflammation and hidden diseases 217
Skin Manifestations Associated with COVID-19 : Current Knowledge and Future Perspectives 214
Hidradenitis suppurativa and adalimumab in the COVID-19 era 214
Paradoxical Skin Reactions to Biologics in Patients With Rheumatologic Disorders 213
Post-surgical thyroid bed pyoderma gangrenosum mimicking recurrent papillary thyroid carcinoma 203
A Systematic Review of Treatment Options and Clinical Outcomes in Pemphigoid Gestationis 203
Linear IgA bullous dermatosis in adults and children: A clinical and immunopathological study of 38 patients 197
Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients 196
Mechanisms of Inflammation in Neutrophil-Mediated Skin Diseases 190
Outbreak of chilblain-like acral lesions in children in the metropolitan area of Milan, Italy, during the COVID-19 pandemic 186
Dermatological Manifestations in Inflammatory Bowel Diseases 186
Cutaneous manifestations in patients with COVID-19 : a preliminary review of an emerging issue 176
Italian guidelines for the diagnosis and treatment of classic and iatrogenic Kaposi's sarcoma 175
New insights into the pathogenesis of bullous pemphigoid : 2019 update 172
Cutaneous metastasis from breast carcinoma clinically mimicking pyogenic granuloma 168
Keratosis lichenoides chronica: A case report and focused overview of the literature 168
Coexistence of Kaposi's sarcoma and psoriasis : is there a hidden relationship? 163
Secondary syphilis masquerading as lupus vulgaris in an HIV-infected patient: A diagnosis suggested by histology 157
SYNDROMIC HIDRADENITIS SUPPURATIVA: GENOTYPE-PHENOTYPE CORRELATION THROUGH WHOLE-EXOME SEQUENCING IN 10 UNRELATED PATIENTS 153
SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris 149
Urticarial eruption in a patient with intermittent fever and monoclonal IgM gammopathy 149
European guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology – Part I 145
Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments 144
An integrated approach to unravel hidradenitis suppurativa etiopathogenesis 144
Primary syphilis of the neck mimicking a pyodermatitis 144
Autoimmune bullous diseases in non-HIV Kaposi's sarcoma : a retrospective study in a large cohort of patients 143
Clinical and serological predictors of relapse in pemphigus: a study of 143 patients 142
European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology – Part II 142
Necrobiotic xanthogranuloma in IgG-κ multiple myeloma 141
PD-L1 expression in tumour microenvironment supports the rationale for immune checkpoint blockade in classic Kaposi's sarcoma 140
Oesophagitis dissecans superficialis as the presenting sign oisolated oesophageal mucous membrane pemphigoid 138
An ulcer on the lower lip 133
Ultrasonographic findings in primary umbilical endometriosis 129
Case report: A case of anti-laminin 332 mucous membrane pemphigoid associated with severe pharyngolaryngeal involvement 128
Chronic spontaneous urticaria in clinical practice: a pilot survey about attitudes and perceptions on assessment, diagnostic work-up and dietary management 127
A dermatologic perspective on autoinflammatory diseases 125
Lichen planopilaris and dermatitis herpetiformis: a fortuitous association? 125
Autoimmune bullous diseases during pregnancy : insight into pathogenetic mechanisms and clinical features 124
Comment on: Treatment of psoriasis with ustekinumab in a patient with HIV-related Kaposi sarcoma 124
Aberrant breast tissue in complete androgen insensitivity syndrome 123
Ulcerative injection site reaction after third COVID-19 vaccine dose with mRNA-1273 122
Iatrogenic Kaposi's Sarcoma : a Retrospective Cohort Study in an Italian Tertiary Care Centre 122
Lichen planus hypertrophicus-inversus occurring in a patient with Bannayan-Riley-Ruvalcaba syndrome 117
A sweet fever 115
Eosinophilic Dermatoses: Recognition and Management 115
Skin barrier status during dupilumab treatment in patients with severe atopic dermatitis 115
Varicella-like exanthem associated with COVID-19 in an 8-year-old girl : a diagnostic clue? 114
Multisystem Inflammatory Syndrome in Children Associated with COVID-19: A Review with an Emphasis on Mucocutaneous and Kawasaki Disease-Like Findings 112
Clinical, genetic, and ultrasonographic features of periumbilical perforating pseudoxanthoma elasticum 111
Acetaminophen-induced generalized fixed drug eruption in a 5-year-old girl 109
Dermal Amyloid Deposits: A Possible Misleading Pathologic Finding 108
Multiple nodules on the scrotal wall 108
25-Hydroxyvitamin D serum levels inversely correlate to disease severity and serum C-reactive protein levels in patients with hidradenitis suppurativa 107
The clinical spectrum of COVID-19-associated cutaneous manifestations: an Italian multicentre study of 200 adult patients 106
Ultrasonographic intraoperative monitoring and follow-up of Kaposi's sarcoma nodules under treatment with intralesional vincristine 105
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review 104
Bullous pemphigoid associated with COVID-19 vaccines : An Italian multicentre study 101
Five cases of new-onset pemphigus following vaccinations against coronavirus disease 2019 100
SARS-CoV-2 Detection by Digital Polymerase Chain Reaction and Immunohistochemistry in Skin Biopsies from 52 Patients with Different COVID-19-Associated Cutaneous Phenotypes 100
Therapeutic management of chronic spontaneous urticaria in clinical practice: results from a pilot survey 100
Clinical and laboratory features of 244 men with primary syphilis: a 5-year single-centre retrospective study 94
The Intriguing Links between Psoriasis and Bullous Pemphigoid 93
Imatinib-induced pyoderma gangrenosum in a patient with chronic myeloid leukemia 92
Baseline D-dimer plasma levels correlate with disease activity but not with the response to omalizumab in chronic spontaneous urticaria 91
Pustular psoriasis : from pathophysiology to treatment 90
Treatment of Autoimmune Bullous Diseases During Pregnancy and Lactation : A Review Focusing on Pemphigus and Pemphigoid Gestationis 88
Eruptive pyogenic granulomas following coronavirus disease 2019 88
Urticarial vasculitis: Clinical and laboratory findings with a particular emphasis on differential diagnosis 87
Clinical and histopathologic study of 39 patients with imported tungiasis 86
Successful treatment of co-existent SAPHO syndrome and hidradenitis suppurativa with adalimumab and methotrexate 85
Bullous erythroderma: novel association of pityriasis rubra pilaris with bullous pemphigoid 84
Case of a severe vulgaris and foliaceus pemphigus in a young patient treated with rituximab, with subsequent development of chronic urticaria 83
Venous Thromboembolism in Chronic Inflammatory Skin Diseases-The Need to Consider Bullous Pemphigoid 83
Cutaneous adverse reactions following SARS-CoV-2 vaccine booster dose: a real-life multicentre experience 83
Pyoderma gangrenosum-like ulcerations in granulomatosis with polyangiitis : two cases and literature review 82
Rosacea-like cutaneous localization of small lymphocytic lymphoma unmasked by high-frequency-ultrasound 80
Reply to “New-onset bullous pemphigoid after inactivated Covid-19 vaccine: Synergistic effect of the Covid-19 vaccine and vildagliptin” 77
Tinea corporis caused by Trichophyton equinum in a rider and review of the literature 76
Genetic screening in new onset inflammatory bowel disease during anti-interleukin 17 therapy: unmet needs and call for action 76
Brunsting-Perry pemphigoid: a systematic review 76
Ultraviolet A phototest positivity is associated with higher free erythrocyte protoporphyrin IX concentration and lower transferrin saturation values in erythropoietic protoporphyria 70
Altered keratinization and vitamin D metabolism may be key pathogenetic pathways in syndromic hidradenitis suppurativa: a novel whole exome sequencing approach 68
Daylight methyl-aminolevulinate photodynamic therapy versus ingenol mebutate for the treatment of actinic keratoses : an intraindividual comparative analysis 68
Response to "Reply to 'Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients': To consider varicella-like exanthem associated with COVID-19, virus varicella zoster and virus herpes simplex must be ruled out" 67
Idiopathic chilblains in myelomonocytic leukemia : not a simple association 64
IgE and D-dimer baseline levels are higher in responders than nonresponders to omalizumab in chronic spontaneous urticaria 64
Follicular larva migrans 63
Miescher nevus as devil's mark, but also as beauty mark 57
Gliptin-associated bullous pemphigoid shows peculiar features of anti-BP180 and -BP230 humoral response: Results of a multicenter study 55
Totale 17.771
Categoria #
all - tutte 51.037
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.037


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.214 0 0 0 0 0 0 165 197 185 205 147 315
2021/20222.506 144 205 233 190 190 216 187 222 236 184 169 330
2022/20232.461 256 198 165 215 238 324 147 193 216 134 249 126
2023/20242.291 163 180 184 186 315 191 166 146 122 159 217 262
2024/20253.626 197 385 174 308 318 215 133 348 250 280 346 672
2025/20263.458 607 422 616 612 604 404 193 0 0 0 0 0
Totale 17.905